Alessandro Leonetti

MD, PhD. Medical Oncologist at University Hospital of Parma, Italy.

[Alessandro Leonetti @Ale_leonetti]

University Hospital of Parma at #WCLC2025 in Barcelona 🇪🇸 with 2 awards, 2 oral presentations and 6 posters!

Proud of our thoracic multidisciplinary group led by Prof @MarcelloTiseo. Good job! 🫁🔬🏆

#LungCancer #Italianresearch

[Alessandro Leonetti @Ale_leonetti]

Honored to present the results of the LiBRA study at #WCLC25, focusing on patients with #BRAF V600E–mutant #NSCLC treated with dabrafenib + trametinib.

An important step towards molecular monitoring in this rare NSCLC subset.

#lungcancer #liquidbiopsy #GOIRC

[Rami Manochakian MD, FASCO @RManochakian]

🚨@OncoAlert Hot Off The Press
Just presented @ASCO #ASCO25

Results of #ALNEO phase 2 trial of:

#Neoadjuvant #Alectinib in potentially resectable stage Ill #ALK+ Non-Small Cell #LungCancer

✅pCR: 12%
✅MPR: 46%
✅ORR: 67%
✅Safety profile consistent with previous studies

[Lodovica Zullo @LodovicaZullo]

Italians are everywhere - #WCLC2024 edition @pecci_federica1 @DiFedericoMD @Ale_leonetti @EdoardoGarbo @BiagioRicciutMD @lorenzobellu @dmarinelli93 @RobertoFerrara_

[Alessandro Leonetti @Ale_leonetti]

An honor to present the IA results of #ALNEO phII trial of #neoadjuvant #alectinib in potentially resectable stage III #ALK+ #NSCLC at @IASLC #WCLC2024:

➡️ 18 pts included in IA
✅ MPR 39%, pCR 17%, no relevant toxicity

Final analysis on 33 pts awaited!

[Alessandro Leonetti @Ale_leonetti]

Happy to share our latest manuscript on liquid biopsy and 18F-FDG PET as noninvasive predictors of 1L #osimertinib outcome in #EGFR-mutated #NSCLC.

Thanks to all the team!

https://t.co/cfEjBQK43x

[Roberto Ferrara @RobertoFerrara_]

Best post award for waning effect of adjuvant EGFR TKIs in resected NSCLC. Cochrane Metanalysis Lung Cancer Group. @CochraneLibrary @cochranecollab @MOcchipintiMD @MImbimbo1 @vittoriosimeon @giusvisc
#ELCC24

[Alessandro Russo @Al3ssandroRusso]

Wonderful educational section on Liquid Biopsy in clinical practice at the #ELCC24 with an outstanding panel of experts @UmbertoMalapel1 @CharuAggarwalMD Natasha Leighl and T. Mitsudomi @myESMO @IASLC

[Alessandro Leonetti @Ale_leonetti]

Great honor to present the results of LiBRA study on liquid biopsy in BRAF V600E-mutated NSCLC treated with 1L dabrafenib + trametinib! 🧪🫁#ELCC2024 #GOIRC #LiBRA

[Alessandro Leonetti @Ale_leonetti]

Our RW study of first-line pembrolizumab plus platinum-pemetrexed in Italian patients with advanced non-squamous lung cancer is out on Eur J Cancer!

➡️ 1068 pts
➡️ mOS 16.1m, mPFS 9.9m, ORR 43.4%
➡️ Favourable outcomes in PD-L1 < 1%

👉 https://t.co/GKQyhRNpx6

Great teamwork!

[Alessandro Leonetti @Ale_leonetti]

@PrelajArsela @polimi @marinagarassino @protoss1986 @jnkath @saramoccia @AI_ON_Lab @IstTumori Congrats Arsela!

[Alessandro Leonetti @Ale_leonetti]

Check our latest work published in @BrJCancer!
We characterized resistance mechanisms to #osimertinib in paired #tissue and #liquidbiopsy in #EGFRmut #NSCLC. Thanks to the #team for the great work!

➕ https://t.co/KqS9tGSRDL

[Targeted Oncology @TargetOncology]

Intrinsic Resistance to #Osimertinib in EGFR Mutated #NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators https://t.co/EF3JUTWlY8

[IASLC @IASLC]

Congratulations to all the @IASLC Academy Program 2022 & 2023 Recipients! @mkbaine @MarianaBrandao0 @FCortiula @DiFedericoMD @ajuloorimd @MMarmarelis @VMenezesMD @pecci_federica1, @pedrofsrocha @xako22 @drshieldsmd #WCLC23 #LCSM

[Rami Manochakian MD, FASCO @RManochakian]

🚨🔥The future of #ThoracicOncology is in great hands!
The 2023 @IASLC #Academy, for #EarlyCareer #Physicians & #Researchers, meeting at #WCLC23 in Singapore.
Outstanding presentations by amazing members/mentees.

Honored to serve as a faculty along with great colleagues @ChristianRolfo @LuisRaezMD @marinagarassino @AnneTsao2 @JPatelMD @acmoorephd @JackWestMD & others.
#LCSM #LungCancer.

[Yeon Wook Kim @kimyw_snu_pulm]

What a fantastic event!
Happy to be part of this group!

[Christian Rolfo @ChristianRolfo]

Great day with the @IASLC Academy participants! #WCLC23 @marinagarassino @RManochakian @UmbertoMalapel1 @Piuchagarrido @triparnasen @karenkellymd @HwakeleeMD @LuisRaezMD @danieltanmd